Obrad Zelić

Obrad Zelic (Serbian Cyrillic: Oбрад Зелић) is a professor of parodontology and oral medicine at the University of Belgrade's Faculty of Stomatology, and a guest professor at faculties in Moscow, Yerevan, Toronto, Winnipeg, Athens, and Jerusalem. He was the first to graduate in the class of 1970, and became a docent before his 33rd birthday in 1979.

Obrad Zelić

The BULLETIN OF THE SERBIAN MEDICAL SOCIETY listed him as having been awarded The Serbian Medical Society's Lifetime Achievement Award in 2009 (Награда за животно дело).^[1]

He is President of the Association of Dentists of Serbia.^[2]

Research

He was the chief researcher on 6 scientific projects, and now an associate on the Serbian Ministry of Science and Technology project titled “THE ETIOLOGY, RISK FACTORS AND THERAPY OF DISEASES OF THE PARODONTIUM” no. 1552. He also worked on "REGENERATIVE TREATMENT OF PROGRESSIVE PERIODONTITIS USING DIFFERENT ALOPLASTIC MATERIALS," with colleagues from Germany, Canada and the US. He was made honorary doctor of sciences at the University of Yerevan's Medical School in 1995.

Zelic is an innovator in the introduction of new healing preparations. He is the maker of a patent for the anti-septic solution for healing the inflammation of the mouth cavity and gullet – Ozosept (1993) and Ozosept-Gel (1999). The Ozosept solution (patent no. P-252/1993, registration no. 48539/1998) has become part of clinical and ambulance practice in Serbia and most countries in the surrounding region.^[3]

He headed (1989–2001) the design of and pre-clinical and clinical studies on the production of the first artificial bone made in Serbia (Aldovit-1).^{[citation needed]}